Clinical Effects of Activated Charcoal Unavailability on Treatment Outcomes for Oral Drug Poisoned Patients

Table 2

Toxic substances ingested by patients.

	Charcoal-available period	Charcoal-unavailable period
CNS Affecting Drug, n (%)	134 (32.4%)	77 (34.8%)
Benzodiazepine, n (%)	21 (5.1%)	8 (3.6%)
Acetaminophen, n (%)	16 (3.9%)	8 (3.6%)
Cardiovascular drug, n (%)	4 (1.0%)	4 (1.8%)
Salicylate, n (%)	6 (1.5%)	1 (0.5%)
OTC drugs, n (%) †	9 (2.2%)	7 (3.2%)
Two or more toxin types, n (%)	132 (32.0%)	73 (33.0%)
Others, n (%)	51 (12.3%)	26 (11.8%)
Unknown, n (%)	40 (9.7%)	17 (7.7%)

CNS: central nervous system; OTC: over the counter.
Except benzodiazepine.
^†Substances not clearly identified.